Ticker

NBIX

Name

Neurocrine Biosciences Inc

Price

Loading...

Sector

Health Care

26th Jul, 2021

Total Mark

86

Above 70 is preferred

Stock Analysis

Growth Potential
94
Profitability
88
Financial Strength
83
Q3 2020 Result
42
Q2 2020 Result
100
Result 2019
83

Growth Estimate

21 Estimate22 Estimate
Revenue Growth (%)17.324.4
EPS Growth (%)63.838.8
ROE (%)35.334.2
P/E (times)......

Market Analysis

Market Sentiment
43
Relative Valuation
98
Being a Value Stock
59
Absolute Valuation
NA

For more detailed information about Neurocrine Biosciences Inc, please go to Yahoo Finance